The role of kinesin family proteins in tumorigenesis and progression: potential biomarkers and molecular targets for cancer therapy.
about
A method for multiprotein assembly in cells reveals independent action of kinesins in complexSumoylation of Kif18A plays a role in regulating mitotic progressionNew therapeutic targets in soft tissue sarcoma.High expression of KIF26B in breast cancer associates with poor prognosisThe motor protein KIF14 inhibits tumor growth and cancer metastasis in lung adenocarcinomaElevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancerSimul-seq: combined DNA and RNA sequencing for whole-genome and transcriptome profiling.Up-regulation of KIF14 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in cervical cancerMiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B geneSuppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers.MAPping out distribution routes for kinesin couriers.Kinesin spindle protein (KSP) inhibitors in combination with chemotherapeutic agents for cancer therapy.Targeting mitotic pathways for endocrine-related cancer therapeutics.Inhibition of KIF22 suppresses cancer cell proliferation by delaying mitotic exit through upregulating CDC25C expression.Suppression of KIF14 expression inhibits hepatocellular carcinoma progression and predicts favorable outcome.Regulation of paclitaxel activity by microtubule-associated proteins in cancer chemotherapy.Identification of Kinesin-1 Cargos Using Fluorescence Microscopy.STARD9/Kif16a is a novel mitotic kinesin and antimitotic target.Kinesin family member 14 in human oral cancer: A potential biomarker for tumoral growth.Expression signatures of early-stage and advanced medaka melanomas.First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer.Functional analysis of KIF20A, a potential immunotherapeutic target for glioma.Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma.Sox17 inhibits hepatocellular carcinoma progression by downregulation of KIF14 expression.Identification of a novel biomarker in tangeretin‑induced cell death in AGS human gastric cancer cellsIdentification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics AnalysisCEP55 is a determinant of cell fate during perturbed mitosis in breast cancer
P2860
Q30597249-0A451A38-10B2-4E07-8BBF-918EC3E71024Q30636955-8CC8C497-3C05-40C3-9432-EF7055AA68DBQ34267924-AB1C17FC-0529-47D3-90A7-C877AB727BC9Q34668047-AFBF8599-ACA9-4CE5-8AB9-9350C63715D6Q34692260-FF12A3B9-C76B-44A9-893D-E6596E362BCBQ35067286-F80FA124-4C3C-4B69-8E05-6589F3486E42Q36159205-E4101996-3C1F-4387-9CDA-F0E37057CF61Q36765087-14C23DE9-A22B-4081-A441-2243F373E665Q37154118-D9B92696-7767-4F67-AFBE-1C4F8A90CDCBQ37644935-C84EFE70-7612-43DD-94C7-F90D6AEA692EQ37702094-6F0ED8E0-3789-45D5-8596-8C4709F63009Q38116595-3915CF1F-1E32-49D2-8B3E-72E2552E85B4Q38130485-5BAE09E0-B827-44D0-AFA1-D91B190F355DQ38671036-13370F2D-5FBF-4D4C-BF6D-C2AB239F23FCQ39015868-77D8F29B-8FAD-4A56-A018-F10AEFE864B5Q39193699-E733F2A8-14A4-4D54-9FDC-6CAB487CF02CQ39456292-7304B083-037C-4C4B-8EEB-2B5D61B709C9Q40049234-30A5B811-4634-4A05-9B07-9C97F69BFE33Q42215485-21EA8BC9-F985-438F-B0D4-6F59FE9120EEQ47094090-3A22AF95-8B45-4426-9B50-465DCD4E313CQ47182822-07F1057C-7639-46CE-8B94-D7751A2A271BQ47575129-55914727-02BF-4F8F-8D1B-8091F9FD99DAQ48364471-98476FFD-225D-4EB7-8166-C2BA03C46977Q49358769-54252A28-9EC3-411A-9A70-71103E28F248Q51064043-72505B8F-4B1B-4037-AD27-44DB9CDD2312Q57070574-98F2A784-D98F-41F6-8F1B-1861B2BF0E8DQ58739996-AB835EB5-85E1-434B-8EDB-43EB6441B7A1Q58779939-BF4D4918-8F75-4115-A823-D031A74C550B
P2860
The role of kinesin family proteins in tumorigenesis and progression: potential biomarkers and molecular targets for cancer therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
The role of kinesin family pro ...... ar targets for cancer therapy.
@en
The role of kinesin family pro ...... ar targets for cancer therapy.
@nl
type
label
The role of kinesin family pro ...... ar targets for cancer therapy.
@en
The role of kinesin family pro ...... ar targets for cancer therapy.
@nl
prefLabel
The role of kinesin family pro ...... ar targets for cancer therapy.
@en
The role of kinesin family pro ...... ar targets for cancer therapy.
@nl
P2860
P356
P1433
P1476
The role of kinesin family pro ...... ar targets for cancer therapy.
@en
P2093
P2860
P304
P356
10.1002/CNCR.25461
P407
P577
2010-11-01T00:00:00Z